Single particle assay of coronavirus membrane fusion with proteinaceous receptor-embedded supported bilayers

Biomaterials

Volumn 34, Issue 32, 2013, Pages 7895-7904

  Costello, Deirdre A ^a   Millet, Jean K ^b   Hsia, Chih Yun ^a   Whittaker, Gary R ^b   Daniel, Susan ^a  

^a Cornell University   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Coronavirus; Fusion kinetics; Membrane fusion; Supported lipid bilayers

Indexed keywords

CELLULAR COMPONENTS; CORONAVIRUSES; MEMBRANE FUSION; MEMBRANE PROTEINS; QUANTITATIVE KINETICS; SINGLE PARTICLE TRACKING; SUPPORTED LIPID BILAYERS; TOTAL INTERNAL REFLECTION MICROSCOPY;

CYTOLOGY; DISEASES; KINETICS; LIPID BILAYERS; REFRACTIVE INDEX; VIRUSES;

CELL MEMBRANES;

MICROSOMAL AMINOPEPTIDASE; PROTEINACEOUS RECEPTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL COMPONENT; CORONAVIRUS; IN VIVO STUDY; MAMMAL CELL; MEMBRANE FUSION; MEMBRANE VESICLE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS PARTICLE; VIRUS VIRULENCE;

CORONAVIRUS; FELIDAE; FELINE CORONAVIRUS; MAMMALIA; SARS CORONAVIRUS;

EID: 84881025868     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.034     Document Type: Article

References (44)

1. Bolles M., Donaldson E., Baric R. Sars-cov and emergent coronaviruses: viral determinants of interspecies transmission. Curr Opin Virol 2011, 1(6):624-634.
2. Raj V.S., Mou H., Smits S.L., Dekkers D.H.W., Muller M.A., Dijkman R., et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 2013, 495(7440):251-254.
3. de Groot R.J., Baker S.C., Baric R.S., Brown C.S., Drosten C., Enjuanes L., et al. Middle east respiratory syndrome coronavirus (MERS-CoV); announcement of the coronavirus study group. JVirol 2013, 87:7790-7792.
4. Axelrod D., Burghardt T.P., Thompson N.L. Total internal reflection fluorescence. Ann Rev Biophys Bioeng 1984, 13:247-268.
5. Floyd D.L., Ragain J.R., Skehel J.J., Harrison S.C., van Oijen A.M. Single-particle kinetics of influenza virus membrane fusion. Proc Natl Acad Sci U S A 2008, 105:15382-15387.
6. Ivanovic T., Rozendaal R., Floyd D.L., Popvic M., Van Oijen A.M., Harrison S.C. Kinetics of proton transport into influenza virions by the viral m2 channel. PLoS ONE 2012, 7:e31566.
7. Costello D.A., Lee D.W., Drewes J., Vasquez K.A., Kisler K., Weisner U., et al. Influenza virus-membrane fusion triggered by proton uncaging for single particle studies of fusion kinetics. Anal Chem 2012, 84:8480-8489.
8. Wessels L., Elting M.W., Scimeca D., Weninger K. Rapid membrane fusion of individual virus particles with supported lipid bilayers. Biophys J 2007, 93:526-538.
9. Matos P.M., Marin M., Ahn B., Lam W., Santos N.C., Melikyan G.B. Anionic lipids are required for vesicular stomatitis virus G protein-mediated single particle fusion with supported lipid bilayers. JBiol Chem 2013, 288(18):12416-12425.
10. Graham R.L., Baric R.S. Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. JVirol 2010, 84(7):3134-3146.
11. Tresnan D.B., Levis R., Holmes K.V. Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. JVirol 1996, 70(12):8669-8674.
12. Tusell S.M., Schittone S.A., Holmes K.V. Mutational analysis of aminopeptidase N, a receptor for several group I coronaviruses, identifies key determinants of viral host range. JVirol 2007, 81(3):1261-1273.
13. Yeager C.L., Ashmun R.A., Williams R.K., Cardellichio C.B., Shapiro L.H., Look A.T., et al. Human aminopeptidase N is a receptor for human coronavirus 229e. Nature 1992, 357(6377):420-422.
14. Scott R.E., Perkins R.G., Zschunke M.A., Hoerl B.J., Maercklein P.B. Plasma membrane vesiculation: a new technique for isolation of plasma membranes. Science 1976, 194:743-745.
15. Holowka D., Baird B. Structural studies on the membrane-bound immunoglobulin E-receptor complex.1. Characterization of large plasma-membrane vesicles from rat basophilic leukemia-cells and insertion of amphipathic fluorescent-probes. Biochemistry 1983, 22(14):3466-3474.
16. Baumgart T., Hammond A.T., Sengupta P., Hess S.T., Holowka D.A., Baird B.A., et al. Large-scale fluid/fluid phase separation of proteins and lipids in giant plasma membrane vesicles. Proc Natl Acad Sci U S A 2007, 104(9):3165-3170.
17. Sezgin E., Kaiser H.-J., Baumgart T., Schwille P., Simons K., Levental I. Elucidating membrane structure and protein behavior using giant plasma membrane vesicles. Nat Protoc 2012, 7(6):1042-1051.
18. Costello D.A., Hsia C.-Y., Millet J.K., Porri T., Daniel S. Membrane fusion-competent virus-like proteoliposomes and proteinaceous supported bilayers made directly from cell plasma membranes. Langmuir 2013, 29(21):6409-6419.
19. Bosch B.J., Rottier P.J. Nidovirus entry into cells. Nidoviruses 2008, 157-178. ASM Press, Washington DC. S. Perlman, T. Gallagher, E.J. Snijder (Eds.).
20. White J.M., Delos S.E., Brecher M., Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 2008, 43(3):189-219.
21. Bosch B.J., van der Zee R., de Haan C.A., Rottier P.J. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. JVirol 2003, 77(16):8801-8811.
22. Belouzard S., Millet J.K., Licitra B.N., Whittaker G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 2012, 4:1011-1033.
23. Madu I.G., Roth S.L., Belouzard S., Whittaker G.R. Characterization of a highly conserved domain within the severe acute respiratory syndrome coronavirus spike protein S2 domain with characteristics of a viral fusion peptide. JVirol 2009, 83(15):7411-7421.
24. Matsuyama S., Ujike M., Morikawa S., Tashiro M., Taguchi F. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci U S A 2005, 102(35):12543-12547.
25. Regan A.D., Shraybman R., Cohen R.D., Whittaker G.R. Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses. Vet Microbiol 2008, 132(3-4):235-248.
26. Sobo K., Chevallier J., Parton R.G., Gruenberg J., van der Goot F.G. Diversity of raft-like domains in late endosomes. PLoS ONE 2007, 2(4):e391.
27. Hoekstra D., de Boer T., Klappe K., Wilschut J. Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 1984, 23:5675-5681.
28. Loyter A., Citovsky V.B.R. The use of fluoroescence dequenching measurements to follow viral membrane fusion events 1988, John Wiley & Sons, Inc. D. Glick (Ed.).
29. Soumpasis D.M. Theoretical analysis of fluorescence photobleaching recovery experiments. Biophys J 1983, 41:95-97.
30. Hohdatsu T., Izumiya Y., Yokoyama Y., Kida K., Koyama H. Differences in virus receptor for type I and type II feline infectious peritonitis virus. Arch Virol 1998, 143(5):839-850.
31. Taylor A. Aminopeptidases: structure and function. FASEB J 1993, 7(2):290-298.
32. Reguera J., Santiago C., Mudgal G., Ordoño D., Enjuanes L., Casasnovas J.M. Structural bases of coronavirus attachment to host aminopeptidase N and its inhibition by neutralizing antibodies. PLoS Pathogens 2012, 8(8):e1002859. 10.1371/journal.ppat.1002859.
33. Kominami E., Ueno T., Muno D., Katunuma N. The selective role of cathepsins b and d in the lysosomal degradation of endogenous and exogenous proteins. FEBS Lett 1991, 287(1-2):189-192.
34. Huang I.C., Bosch B.J., Li F., Li W., Lee K.H., Ghiran S., et al. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin l to infect ace2-expressing cells. JBiol Chem 2005, 10:3198-3203.
35. Qiu Z., Hingley S.T., Simmons G., Yu C., Das Sarma J., Bates P., et al. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. JVirol 2006, 80(12):5768-5776.
36. Simmons G., Rennekamp A.J., Bates P. Proteolysis of SARS-associated coronavirus spike glycoprotein. Adv Exp Med Biol 2006, 581:235-240.
37. Bosch B.J., Bartelink W., Rottier P.J. Cathepsin l functionally cleaves the SARS-CoV class I fusion protein upstream of rather than adjacent to the fusion peptide. JVirol 2008, 82(17):8887-8890.
38. Rawlings N.D., Barrett A.J. Families of serine peptidases. Methods in enzymology 1994, 19-61. Academic Press. J.B. Alan (Ed.).
39. Belouzard S., Chu V.C., Whittaker G.R. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A 2009, 106(14):5871-5876.
40. Floyd D.L., Harrison S.C., van Oijen A.M. Analysis of kinetic intermediates in single-particle dwell-time distributions. Biophys J 2010, 99:360-366.
41. Brian A.A., McConnell H.M. Allogeneic stimulation of cytotoxic T cells by supported planar membranes. Proc Natl Acad Sci U S A 1984, 81:6159-6163.
42. Yang T., Jung S.-Y., Mao H., Cremer P.S. Fabrication of phospholipid bilayer-coated microchannels for on-chip immunoassays. Anal Chem 2001, 73:165-169.
43. Stegmann T., White J.M., Helenius A. Intermediates in influenza induced membrane fusion. EMBO J 1990, 9:4231-4241.
44. Blumenthal R., Schoch C., Puri A., Clague M.J. Adissection of steps leading to viral envelope protein-meditaed membrane fusion. Ann New York Acad Sci 1991, 635:285-296.